Devices › Device types
FDA product code MXC · class 2 · Cardiovascular
Recorder, event, implantable cardiac, (without arrhythmia detection): medical device reports filed with FDA
11,316 reports carry this product code, 2001–2026; 6 brands with a page.
- 11,316
- reports with this product code
- 0% of all MAUDE reports
- 1,347
- reports, 12 months to August 2026
- 1,057 in the 12 months before
- 85.7%
- classified as malfunction
- 62.3% across all reports
- 0.2%
- classified as death, as reported
- 0.9% across all reports
Product code MXC is FDA's classification for "Recorder, event, implantable cardiac, (without arrhythmia detection)" (cardiovascular panel), a class 2 device. 11,316 medical device reports carry this product code, 0% of the MAUDE database, from May 2001 to August 2026.
1,347 reports arrived in the 12 months to August 2026, up 27% from 1,057 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (85.7%), injury (14.1%) and death (0.2%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Confirm | 7,752 | 34 | 0.1% | 85.8% |
| Assert-IQ ICM | 2,350 | 1,162 | 0% | 88.7% |
| Jot Dx ICM | 1,071 | 139 | 0.1% | 84.3% |
| LUX-Dx Insertable Cardiac Monitor | 2 | 83 | 0% | 10.2% |
| Diamondback 360 Coronary Orbital Atherectomy System | 1 | 0 | 15.7% | 8.1% |
| Reveal LINQ | 1 | 264 | 0% | 93.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| St Jude Medical Crm-Sylmar | 6,309 | 55.8% |
| Abbott | 1,564 | 13.8% |
| St Jude Medical Crm-Sunnyvale | 1,006 | 8.9% |
| Abbott Medical Crm-Sylmar | 593 | 5.2% |
| St Jude Medical Crmd | 584 | 5.2% |
| St Jude Medical | 571 | 5% |
| St Jude Medical Cardiac Rhythm Management Division | 197 | 1.7% |
| St Jude Medical Crm-Kista | 83 | 0.7% |
| St Jude Medical Cardiac Rhythm Management Divisi | 76 | 0.7% |
| Medtronic Med Rel | 14 | 0.1% |
| Covidien Medical Products | 3 | 0% |
| Cardiovascular Systems | 1 | 0% |
| Medtronic Puerto Rico Operations Juncos | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Under-sensing | 4,576 | 40.4% |
| Failure to interrogate | 1,659 | 14.7% |
| Over-sensing | 1,333 | 11.8% |
| Premature discharge of battery | 637 | 5.6% |
| Data problem | 479 | 4.2% |
| Incorrect measurementthe device measured wrongly | 410 | 3.6% |
| Signal artifact/noise | 405 | 3.6% |
| Pacemaker found in back-up mode | 300 | 2.7% |
| Failure to sense | 269 | 2.4% |
| Device displays incorrect message | 247 | 2.2% |
| Inappropriate or unexpected reset | 244 | 2.2% |
| Device sensing problem | 180 | 1.6% |
| Incorrect, inadequate or imprecise result or readings | 179 | 1.6% |
| Interrogation problem | 175 | 1.5% |
| Device operates differently than expectedthe device behaved unexpectedly | 161 | 1.4% |
| Wireless communication problema wireless connection problem | 148 | 1.3% |
| Sensing intermittently | 144 | 1.3% |
| Incorrect interpretation of signal | 130 | 1.1% |
| Migration or expulsion of device | 125 | 1.1% |
| Communication or transmission problemthe device could not communicate or transmit | 100 | 0.9% |
Questions about recorder, event, implantable cardiac, (without arrhythmia detection) reports
What is product code MXC?
FDA's classification code for "Recorder, event, implantable cardiac, (without arrhythmia detection)", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
11,316 reports through August 2026, 1,347 of them in the latest 12 months.
Which brands appear most often?
Confirm (7,752), Assert-IQ ICM (2,350), Jot Dx ICM (1,071), LUX-Dx Insertable Cardiac Monitor (2) and Diamondback 360 Coronary Orbital Atherectomy System (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.